The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

20 May 2020 07:00

RNS Number : 3981N
Medica Group PLC
20 May 2020
 

20 May 2020

 

Medica Group Plc

 

AGM Statement

 

Medica Group PLC (LSE:MGP, "Medica" or the "Company"), the UK market leader in the provision of teleradiology services, provides a business update in advance of holding its Annual General Meeting (AGM) at 10.30 a.m. today.

 

As a result of the continuing COVID-19 pandemic and the restrictions on public gatherings imposed by the UK government, the AGM will be convened with the minimum necessary quorum of two shareholders (which will be facilitated by Medica Group) at One Priory Square, Hastings, East Sussex TN34 1EA. Shareholders and any persons other than the two shareholders referred to above will not be permitted to attend the AGM in person. The Board would like to thank shareholders for their co-operation and understanding during these challenging and extraordinary times.

 

Following the AGM, the Board will respond to any questions submitted by shareholders in advance of the meeting and the answers will be posted on the investors section of the Company website.

 

Statement from Roy Davis, Chairman of Medica

 

Current trading and outlook

 

During the COVID-19 pandemic, Medica is complying with government guidance and requirements across its operations to prioritise the health and safety of its employees. In addition, through Medica's business model of providing our operational service remotely from home, we have been able to rapidly respond to the pandemic to ensure continuity of the service and support for our customers.

 

2020 started well, with a strong performance in January and February. However, as the Company stated in a market and trading update on 23 March 2020 and subsequently in its preliminary results announcement on 7 April 2020, the business has been significantly impacted by the COVID-19 pandemic.

 

For Routine reporting, trading remains in-line with guidance provided on 7 April 2020, with activity decreasing by over 95% from pre-COVID levels. For our urgent, out-of-hours "Nighthawk" reporting service, we are encouraged that after experiencing an initial c.50% reduction, activity has begun to increase, and is now approximately two-thirds of activity levels pre-COVID-19.

 

The Board anticipates that Nighthawk activity will continue to increase as our clients work to reinstate normal out-of-hours staffing rotas and attendance at emergency departments increases. Routine activity is expected to take significantly longer to return to pre-COVID-19 levels, with factors such as the uptake of outpatient appointments by the general public, radiology scanning capacity limitations imposed by social distancing, and enhanced cleaning requirements impacting the speed of recovery.

 

The Company will continue to appraise shareholders as the recovery continues and would like to reiterate that it is in a strong cash position with over £20 million on the balance sheet (net cash over £8.0m) at the current time and a further £1 million undrawn facility.

 

Customer support and strategy implementation

 

In March 2020, the Company announced it was supporting its clients with a pro bono 'pass-through' service that would allow our client's radiologists to access their NHS cases remotely using Medica equipment. We are pleased to report the facility has enabled our reporters to provide reports for over 3,000 patients in total since this initiative started.

 

Despite the impact of reduced activity, Medica remains diligent in the recruitment of radiologists, which will increase the Company's reporting capacity once activity resumes. Furthermore, the management team is using this time to focus on implementing the strategy communicated on 23 March 2020 and on operational excellence projects to ensure the Group is fully prepared to support our clients when they need us.

 

On behalf of the Board, I would like to thank our reporters and our central team for their commitment and dedication in adapting so quickly to the challenges faced during the pandemic and continuing to deliver a resilient service remotely.

 

Board changes

 

As announced previously, Tony Lee will be leaving the Company at the end of May 2020. I would like to thank Tony for his service to Medica as Finance Director and wish him well in the future. Additionally, I am looking forward to welcoming Richard Jones to Medica as Chief Financial Officer. On behalf of the Board, I wish him all the best as he joins Medica during this challenging, but exciting time for the Company as we continue to implement our growth strategy.

 

Finally, as also previously announced, Professor Mike Bewick will stand down as a Non-Executive Director and Chair of the Remuneration Committee at the AGM. I would like to thank Mike for his valuable contribution to Medica during his tenure, both from a remuneration committee and clinical perspective. We wish him the very best for the future. Jo Easton will replace Mike as Chair of the Remuneration Committee.

 

For further information, please contact:  

 

Medica Group Plc:

Roy Davis, Chairman

Stuart Quin, Chief Executive Officer

 

+44 (0)33 33 111 222

 

Investec Bank Plc

Sara Hale

Daniel Adams

 

+44 (0)20 7597 5970

FTI Consulting

Victoria Foster Mitchell

Robert Winder

 

+44 (0)20 3727 1000

 

About MEDICA

 

MEDICA is the UK market leader in the provision of teleradiology services, providing outsourced interpretation and reporting on MRI (magnetic resonance imaging), CT (computerised tomography) and plain film (x-ray) images. The Company currently offers three primary services to hospital radiology departments: NightHawk, an out-of-hours service, routine cross-sectional reporting on MRI and CT scans, and routine plain film reporting on x-ray images.

 

MEDICA has developed a bespoke secure IT platform that provides market-leading linkage between a hospital's Radiology Information System (RIS) and Consultant Radiologists who contract with MEDICA. Direct RIS access ensures that the full wider patient information is available and reviewed with every report.

 

The Company contracts with the largest pool of consultant radiologists outside of the NHS and has been trusted to provide more than 1.3 million examinations annually across its customer base of more than 100 NHS Trusts and various private hospital groups and diagnostic imaging companies. For more information please visit www.medicagroup.co.uk 

 

About Teleradiology

Teleradiology is the electronic transmission of radiological patient images, including plain film (x-rays), CT scans and MRI scans, from one location to another for the purposes of diagnostic interpretation and reporting.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMEAKSNFELEEFA
Date   Source Headline
28th May 20213:27 pmRNSDirector/PDMR Shareholding
28th May 20212:43 pmRNSDirector/PDMR Shareholding
25th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
11th May 20217:10 amRNSNon-Executive Director Change
11th May 20217:10 amRNSResults for the year ended 31 December 2020
20th Apr 20219:30 amRNSHolding(s) in Company
16th Apr 20219:47 amRNSHolding(s) in Company
29th Mar 202110:48 amRNSHolding(s) in Company
25th Mar 20218:05 amRNSCompletion of Acquisition & Director/PDMR Dealings
23rd Mar 20219:31 amRNSCorrection: Results of Fundraise and TVR
23rd Mar 20217:00 amRNSResults of Fundraise and Total Voting Rights
23rd Mar 20217:00 amRNSRe-release: Proposed acquisition of US-based RadMD
22nd Mar 20215:07 pmRNSProposed Fundraise to raise approximately £16m
22nd Mar 20215:07 pmRNSProposed acquisition of US-based RadMD
19th Mar 20217:00 amRNSMicrosoft Research’s Dr Junaid Bajwa joins as NED
22nd Feb 20217:00 amRNSMedica and Integral Diagnostics establish JV, MedX
11th Feb 202110:09 amRNSHolding(s) in Company
29th Jan 20219:02 amRNSHolding(s) in Company
26th Jan 20217:00 amRNSAppointment of Liberum as Joint Corporate Broker
21st Jan 20217:00 amRNSTrading Update
18th Jan 20217:00 amRNSDr. Robert Lavis appointed Group Medical Director
4th Dec 202011:57 amRNSDirector/PDMR Shareholding
2nd Dec 20209:31 amRNSDirector/PDMR Shareholding
1st Dec 20209:34 amRNSHolding(s) in Company
18th Nov 20204:41 pmRNSSecond Price Monitoring Extn
18th Nov 20204:36 pmRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSDirector/PDMR Shareholding
11th Nov 202012:41 pmRNSHolding(s) in Company
10th Nov 20201:56 pmRNSHolding(s) in Company
6th Nov 20202:26 pmRNSHolding(s) in Company
5th Nov 20207:00 amRNSDirector/PDMR Shareholding
4th Nov 20207:00 amRNSMedica acquires Global Diagnostics Ireland
27th Oct 20209:20 amRNSHolding(s) in Company
22nd Oct 20209:41 amRNSHolding(s) in Company
16th Oct 202011:26 amRNSHolding(s) in Company
7th Oct 202012:34 pmRNSHolding(s) in Company
16th Sep 20201:07 pmRNSDeclaration of Dividend
14th Sep 20207:00 amRNSInterim results demonstrate resilient performance
9th Sep 202010:36 amRNSHolding(s) in Company
25th Aug 20204:41 pmRNSSecond Price Monitoring Extn
25th Aug 20204:36 pmRNSPrice Monitoring Extension
14th Aug 20209:56 amRNSHolding(s) in Company
21st Jul 202010:49 amRNSHolding(s) in Company
8th Jul 20207:00 amRNSTrading Update
11th Jun 20203:22 pmRNSDirector/PDMR Shareholding
1st Jun 20204:54 pmRNSIssue of Equity
28th May 202010:14 amRNSHolding(s) in Company
21st May 202012:55 pmRNSHolding(s) in Company
20th May 20204:25 pmRNSResult of AGM
20th May 20207:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.